DK1848731T3 - Antibiotika 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse heraf - Google Patents

Antibiotika 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse heraf

Info

Publication number
DK1848731T3
DK1848731T3 DK05712250.9T DK05712250T DK1848731T3 DK 1848731 T3 DK1848731 T3 DK 1848731T3 DK 05712250 T DK05712250 T DK 05712250T DK 1848731 T3 DK1848731 T3 DK 1848731T3
Authority
DK
Denmark
Prior art keywords
antibiotics
factors
compositions
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
DK05712250.9T
Other languages
English (en)
Inventor
Ameriga Lazzarini
Luciano Gastaldo
Gianpaolo Candiani
Ismaela Ciciliato
Daniele Losi
Flavia Marinelli
Enrico Selva
Franco Parenti
Original Assignee
Sentinella Pharmaceuticals Inc Sentinella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentinella Pharmaceuticals Inc Sentinella filed Critical Sentinella Pharmaceuticals Inc Sentinella
Application granted granted Critical
Publication of DK1848731T3 publication Critical patent/DK1848731T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK05712250.9T 2005-01-26 2005-01-27 Antibiotika 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse heraf DK1848731T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/045,628 US7351687B2 (en) 2003-07-18 2005-01-26 Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
PCT/US2005/002733 WO2006080920A1 (en) 2005-01-26 2005-01-27 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof

Publications (1)

Publication Number Publication Date
DK1848731T3 true DK1848731T3 (da) 2012-09-03

Family

ID=36740829

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05712250.9T DK1848731T3 (da) 2005-01-26 2005-01-27 Antibiotika 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse heraf

Country Status (26)

Country Link
US (1) US7351687B2 (da)
EP (2) EP2402366A1 (da)
JP (1) JP4191238B2 (da)
KR (1) KR100896826B1 (da)
CN (1) CN101189252B (da)
AU (1) AU2005326149C1 (da)
BR (1) BRPI0519942A2 (da)
CA (1) CA2593801A1 (da)
CY (1) CY1113030T1 (da)
DK (1) DK1848731T3 (da)
EA (1) EA016608B1 (da)
ES (1) ES2387557T3 (da)
HR (1) HRP20120634T1 (da)
IL (1) IL184377A0 (da)
MA (1) MA29237B1 (da)
MX (1) MX2007009059A (da)
NO (1) NO20073490L (da)
NZ (1) NZ556368A (da)
PL (1) PL1848731T3 (da)
PT (1) PT1848731E (da)
RS (1) RS52427B (da)
SI (1) SI1848731T1 (da)
TN (1) TNSN07286A1 (da)
UA (1) UA87548C2 (da)
WO (1) WO2006080920A1 (da)
ZA (1) ZA200705495B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
JP5719312B2 (ja) 2009-01-14 2015-05-13 ノヴァクタ バイオシステムズ リミティッド デオキシアクタガルジン誘導体
AU2010212183B2 (en) 2009-02-04 2014-07-10 Novacta Biosystems Limited Actagardine derivatives
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59198982A (ja) 1983-04-28 1984-11-10 Meiji Seika Kaisha Ltd 新抗生物質ｓｆ−２２４０物質およびその製造法
EP0592835A3 (en) 1992-09-23 1995-03-15 Bristol Myers Squibb Co Antibiotics of type BU-4803T.
US6551591B1 (en) 2001-09-07 2003-04-22 Essential Therapeutics, Inc. Antibiotics from microbispora
US6551581B1 (en) 2001-12-27 2003-04-22 Avon Products, Inc. Methods for improving the aesthetic appearance of skin and hair
US7307057B2 (en) * 2003-07-18 2007-12-11 Naicons S.C.A.R.L. Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
KR100892655B1 (ko) * 2005-01-12 2009-04-15 비큐론 파마세티컬스 인코포레이티드 항생제 １０７８９１, 그의 팩터 ａ１ 및 ａ２, 제약학상허용되는 염 및 조성물, 및 그의 용도
CN101098707B (zh) * 2005-01-12 2011-11-30 森帝奈拉医药品公司 抗生素107891、其因子a1和a2、可药用盐和组合物及其用途
WO2006075988A1 (en) * 2005-01-12 2006-07-20 Vicuron Pharmaceuticals Inc. Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof

Also Published As

Publication number Publication date
NZ556368A (en) 2010-09-30
TNSN07286A1 (fr) 2008-12-31
ES2387557T3 (es) 2012-09-26
IL184377A0 (en) 2007-10-31
EP1848731B1 (en) 2012-05-23
AU2005326149B2 (en) 2009-10-29
CN101189252A (zh) 2008-05-28
EP1848731A1 (en) 2007-10-31
RS52427B (en) 2013-02-28
EA200701384A1 (ru) 2008-02-28
CA2593801A1 (en) 2006-08-03
KR20070090043A (ko) 2007-09-04
PL1848731T3 (pl) 2012-10-31
CY1113030T1 (el) 2016-04-13
CN101189252B (zh) 2012-07-18
SI1848731T1 (sl) 2012-09-28
AU2005326149A1 (en) 2006-08-03
EA016608B1 (ru) 2012-06-29
PT1848731E (pt) 2012-08-20
UA87548C2 (ru) 2009-07-27
KR100896826B1 (ko) 2009-05-12
AU2005326149C1 (en) 2010-04-01
MA29237B1 (fr) 2008-02-01
NO20073490L (no) 2007-08-07
HRP20120634T1 (hr) 2012-08-31
BRPI0519942A2 (pt) 2009-04-07
JP2008528581A (ja) 2008-07-31
WO2006080920A1 (en) 2006-08-03
EP2402366A1 (en) 2012-01-04
US20050233952A1 (en) 2005-10-20
EP1848731A4 (en) 2008-11-12
US7351687B2 (en) 2008-04-01
MX2007009059A (es) 2008-02-12
ZA200705495B (en) 2008-12-31
JP4191238B2 (ja) 2008-12-03

Similar Documents

Publication Publication Date Title
IL184901A0 (en) 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
IL192298A (en) Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
PT1506781E (pt) Composicao para tratamento vaginal
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
IL175953A (en) Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them
DK1902050T3 (da) Oxazolidinonderivater og anvendelse deraf som antibiotika
IL189781A0 (en) Sulphonylpyrrole hydrochloride salts and pharmaceutical compositions containing the same
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
DK1848731T3 (da) Antibiotika 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse heraf
AU2006321904A8 (en) 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
IL187534A0 (en) Thiazole derivatives, use thereof and pharmaceutical compositions containing them
DK1587478T3 (da) Farmaceutisk sammensætning
ZA200706672B (en) 2,4-Diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors
DK1858481T3 (da) Ophthalmologiske sammensætninger og anvendelse deraf
DK1912644T3 (da) N-(arylalkyl)-1h-pyrrolopyridin-2-carboxamid-derivater, fremstilling deraf og terapeutisk anvendelse deraf
PL394604A1 (pl) Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
DK1812120T3 (da) Hudbeskyttende, alkalinitetskontrollerende præparat og anvendelsen deraf
DK1940840T3 (da) 6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf
BRPI0614413A2 (pt) composto, e, composição farmacêutica
PL1791872T3 (pl) Biotynylowane heksadekasacharydy, kompozycje farmaceutyczne i ich zastosowanie
BRPI0614412A2 (pt) composto, e, composição farmacêutica
ZA200710146B (en) New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
NO344962B1 (no) Amorf cesiumaluminiumfluorklompleks, dets fremstilling og bruk
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
DK1855705T3 (da) Antibiotikum 107891, dets faktorer, farmaceutisk acceptable salte og sammensætninger og anvendelse deraf